M&A TRANSACTION · 2019
Fresenius Kidney Care - Troy acquired by Troy Renal Venture Group
$2.8M· 7.6x EBITDA· 1.10x revenue
Target
Fresenius Kidney Care - Troy
Acquirer
Troy Renal Venture Group
Strategic buyer
Disclosed financials at time of acquisition
Revenue
$2.5M
EBITDA
$0.4M
Deal Value
$2.8M
EV/EBITDA
7.6x
Context
This $2.8M acquisition of Fresenius Kidney Care - Troy by Troy Renal Venture Group sits in the medical practice specialty sub-vertical. The 7.6x EBITDA multiple paid in 2019 can be compared against the population median for medical practice specialty transactions of similar size on our Medical Practice Specialty valuation hub. Troy Renal Venture Group is acquiring as a strategic buyer; see how strategic acquirers typically price medical practice specialty businesses on our Medical Practice Specialty strategic buyer-pool page.
Source
Data sourced from CON filings. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology
Value your own medical practice specialty
Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.
Compare your business to the Fresenius Kidney Care - Troy acquisition.